Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
For 8 weeks, 48 people with PCOS were randomly given 220 mg of zinc sulfate or a placebo drug.The intervention group had significantly reduced alopecia and hirsutism (p < 0.05).RoB 2: MediumForoozanfard et al.6752 patients with PCOS were separated equally into 2 two treatment arms for 8 weeks: 220 mg Zinc sulfate (containing 50 mg zinc) or a placebo group.The intervention group had significantly reduced plasma glucose, serum insulin and insulin resistance (p < 0.05).RoB 2: MediumCalcium14Tehrani et al.4880 people with PCOS were separated into 4 groups and given these interventions for 4 months: metformin or metformin and calcium and vitamin D, or calcium and vitamin D, or placebo.Significant improvement in menstrual cycle regularity was noted in patients with metformin and calcium supplementation.RoB 2: HighFisetin15Mihanfar et al.6824 Wistar rats were given letrozole to induce PCOS.
Source: Identification of bioactive molecules. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The RoB 2 tool, a revised version of the Cochrane tool, assesses for biases in randomized controlled trials with human participants, and SYRCLE, based on Cochrane’s tool, assesses for biases in animal studies.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Identifying nutraceutical targets to treat polycystic ovary syndrome using graph representation learning
Study design awaiting verification · Npj Women's Health · 2025
Original publication title
Identifying nutraceutical targets to treat polycystic ovary syndrome using graph representation learning
© The Author(s) 2025, modified publication 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Polycystic ovary syndrome (PCOS) is a complex, multifactorial, and polygenic disorder. Here, we employed machine learning (ML) techniques to analyze large open-source datasets to identify bioactive molecules in foods and pharmacological agents that interact with genes and biological functions central to PCOS pathophysiology. We selected 13 PCOS-associated genes as targets, and the network propagation algorithm systematically identified bioactive molecules that interact with pathways relevant to PCOS. Among the top-ranked molecules, epicatechin-3-gallate (found in green tea) and 24-methylenecycloartan-3-ol (found in almonds) were newly identified, with green tea and almonds previously demonstrated to have anti-androgenic and anti-inflammatory properties.
Validation of the ML pipeline with clinically available drugs revealed significant interactions with gonadotropin-releasing hormone receptor modulators, consistent with their established role in PCOS pathophysiology. These findings identify novel therapeutic targets for further research in precision nutrition and drug repurposing for PCOS treatment.
Authors’ abstract
Polycystic ovary syndrome (PCOS) is a complex, multifactorial, and polygenic disorder. Here, we employed machine learning (ML) techniques to analyze large open-source datasets to identify bioactive molecules in foods and pharmacological agents that interact with genes and biological functions central to PCOS pathophysiology. We selected 13 PCOS-associated genes as targets, and the network propagation algorithm systematically identified bioactive molecules that interact with pathways relevant to PCOS. Among the top-ranked molecules, epicatechin-3-gallate (found in green tea) and 24-methylenecycloartan-3-ol (found in almonds) were newly identified, with green tea and almonds previously demonstrated to have anti-androgenic and anti-inflammatory properties.
Validation of the ML pipeline with clinically available drugs revealed significant interactions with gonadotropin-releasing hormone receptor modulators, consistent with their established role in PCOS pathophysiology. These findings identify novel therapeutic targets for further research in precision nutrition and drug repurposing for PCOS treatment.
Publication and source details
Original title: Identifying nutraceutical targets to treat polycystic ovary syndrome using graph representation learning
Simon Hanassab; Joshua Southern; Ayomide V. Olabode; Ivan Laponogov; Michael Bronstein; Alexander N. Comninos; Thomas Heinis; Ali Abbara; Chioma Izzi-Engbeaya; Kirill Veselkov; Waljit S. Dhillo
Npj Women's Health · 2025
© The Author(s) 2025, modified publication 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/100014013UK Research and InnovationEP/S023283/1EP/S023283/1http://dx.doi.org/10.13039/100008058Vodafone Foundationhttp://dx.doi.org/10.13039/501100000781European Research Council899932899932http://dx.doi.org/10.13039/501100000266Engineering and Physical Sciences Research CouncilEP/X040062/1http://dx.doi.org/10.13039/501100000272National Institute for Health and Care ResearchCS-2018-18-ST2-002NIHR304591NIHR202371Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:27:35.314488+00:00
DOI: 10.1038/s44294-025-00117-4 · PMC12669042